Larger Phase 3 trials are underway to confirm the long-term safety and benefits before the medication can be considered for approval
Processing takes 2-4 weeks, and approved patients receive 90-day supplies at no cost
Allow vial to equilibrate before opening to prevent condensation
Our work focuses on molecular mechanisms, receptor pharmacology, and preclinical data including GLP-1/GIP/glucagon incretin biology, growth hormone axis peptides (GHRH analogs and ghrelin-receptor secretagogues), mitochondrial-derived peptides (MOTS-c, SS-31), tissue-repair peptides (BPC-157, TB-500, GHK-Cu), and nootropic peptides (Semax, Selank)
The HRT and GLP-1 together guide covers the pharmacological interactions, absorption considerations, and monitoring recommendations for women managing both simultaneously
To that end, always check with your doctor before starting a new exercise program